Untitled Document
  
 

Section B: Pharmaceutical Industry

Opinions of pharmaceutical SMEs in the Mumbai cluster

The survey revealed the various opinions expressed by the respondent SMEs in the cluster. These opinions include: need for huge capital infusion, lack of adequate technology, significance of brand building initiatives, high interest rates, realisation of receivables, need to propel R&D and IT expenditure etc. Among these opinions, ‘the need to increase spending on R&D and IT’ was ranked as the highest. Realisation of receivables and brand building were the other high ranking opinions expressed by the respondent SMEs in the cluster.

Expected business growth

Though majority (66%) of the respondents in the survey were not very optimistic about the industry growth prospect; they come across as fairly positive with regards to their individual growth. Among the respondents in the survey, 48% companies expected to grow between 15% - 30% in FY10 and 45% companies anticipated the same growth rate for FY11.

Industry growth prospects

The respondent SMEs in the survey perceive the growth prospects of the pharmaceutical industry to be fairly stable. According to the survey results, 66% of the respondent pharmaceutical companies in the Mumbai cluster project the pharmaceutical industry to grow by 0-10% in the next 4-5 years.

Cluster benefits

As per the respondent companies in the survey, the cluster provides various benefits that aid in their business operations. Approximately 80% of the respondent companies perceived quality upgradation as a benefit along with other benefits provided by the cluster. Approximately 66% respondents indicated easy availability of funds as a one of the benefits derived from the cluster.

Future plans

As per the respondents in the survey, the pharmaceutical companies in the Mumbai cluster have plans for capacity expansion and tapping new markets in the future.

All the respondent pharmaceutical SMEs in the survey cited capacity expansion as part of their future plans.